Viewpoint Capital Management LLC Cuts Position in The Clorox Company (NYSE:CLX)

Viewpoint Capital Management LLC reduced its position in The Clorox Company (NYSE:CLX) by 2.0% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 7,513 shares of the company’s stock after selling 150 shares during the period. Viewpoint Capital Management LLC’s holdings in Clorox were worth $1,150,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Northwest Financial Advisors purchased a new position in Clorox during the 4th quarter worth $29,000. GoalVest Advisory LLC purchased a new position in Clorox during the first quarter worth about $31,000. Core Wealth Advisors Inc. acquired a new stake in Clorox in the fourth quarter valued at about $29,000. Fortitude Family Office LLC purchased a new stake in Clorox in the 4th quarter valued at approximately $29,000. Finally, First United Bank & Trust acquired a new position in Clorox during the 4th quarter worth approximately $31,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Price Performance

NYSE CLX traded down $0.13 on Friday, reaching $136.47. The company’s stock had a trading volume of 1,667,373 shares, compared to its average volume of 1,254,727. The firm’s 50 day moving average is $136.95 and its two-hundred day moving average is $143.79. The stock has a market cap of $16.95 billion, a PE ratio of 70.72, a PEG ratio of 2.19 and a beta of 0.39. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.14.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company had revenue of $1.81 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter in the prior year, the company earned $1.51 earnings per share. The firm’s revenue was down 5.3% on a year-over-year basis. As a group, sell-side analysts predict that The Clorox Company will post 5.91 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft dropped their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research note on Wednesday, April 17th. Citigroup cut their price objective on Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a research note on Tuesday, March 26th. The Goldman Sachs Group began coverage on Clorox in a report on Friday, March 1st. They set a “sell” rating and a $140.00 target price on the stock. Finally, JPMorgan Chase & Co. decreased their price target on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Five analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $145.33.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.